Literature DB >> 31026827

Predictive factors of incomplete aneurysm occlusion after endovascular treatment with the Pipeline embolization device.

Georgios A Maragkos1, Luis C Ascanio1, Mohamed M Salem1, Sricharan Gopakumar2, Santiago Gomez-Paz1, Alejandro Enriquez-Marulanda1, Abhi Jain3,4, Clemens M Schirmer3, Paul M Foreman1, Christoph J Griessenauer3,5, Peter Kan2, Christopher S Ogilvy1, Ajith J Thomas1.   

Abstract

OBJECTIVE: The Pipeline embolization device (PED) is a routine choice for the endovascular treatment of select intracranial aneurysms. Its success is based on the high rates of aneurysm occlusion, followed by near-zero recanalization probability once occlusion has occurred. Therefore, identification of patient factors predictive of incomplete occlusion on the last angiographic follow-up is critical to its success.
METHODS: A multicenter retrospective cohort analysis was conducted on consecutive patients treated with a PED for unruptured aneurysms in 3 academic institutions in the US. Patients with angiographic follow-up were selected to identify the factors associated with incomplete occlusion.
RESULTS: Among all 3 participating institutions a total of 523 PED placement procedures were identified. There were 284 procedures for 316 aneurysms, which had radiographic follow-up and were included in this analysis (median age 58 years; female-to-male ratio 4.2:1). Complete occlusion (100% occlusion) was noted in 76.6% of aneurysms, whereas incomplete occlusion (≤ 99% occlusion) at last follow-up was identified in 23.4%. After accounting for factor collinearity and confounding, multivariable analysis identified older age (> 70 years; OR 4.46, 95% CI 2.30-8.65, p < 0.001); higher maximal diameter (≥ 15 mm; OR 3.29, 95% CI 1.43-7.55, p = 0.005); and fusiform morphology (OR 2.89, 95% CI 1.06-7.85, p = 0.038) to be independently associated with higher rates of incomplete occlusion at last follow-up. Thromboembolic complications were noted in 1.4% and hemorrhagic complications were found in 0.7% of procedures.
CONCLUSIONS: Incomplete aneurysm occlusion following placement of a PED was independently associated with age > 70 years, aneurysm diameter ≥ 15 mm, and fusiform morphology. Such predictive factors can be used to guide individualized treatment selection and counseling in patients undergoing cerebrovascular neurosurgery.

Entities:  

Keywords:  Pipeline embolization device; aneurysm; interventional neurosurgery; occlusion; prognostic factors; vascular disorders

Year:  2019        PMID: 31026827     DOI: 10.3171/2019.1.JNS183226

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  9 in total

1.  2D parametric contrast time-density analysis for the prediction of complete aneurysm occlusion at six months' post-flow diversion stent.

Authors:  Ahmed E Hussein; Meghana Shownkeen; Andre Thomas; Christopher Stapleton; Denise Brunozzi; Jessica Nelson; John Naumgart; Andreas Linninger; Gursant Atwal; Ali Alaraj
Journal:  Interv Neuroradiol       Date:  2020-02-26       Impact factor: 1.610

2.  The effect of Dean, Reynolds and Womersley numbers on the flow in a spherical cavity on a curved round pipe. Part 2. The haemodynamics of intracranial aneurysms treated with flow-diverting stents.

Authors:  Michael C Barbour; Fanette Chassagne; Venkat K Chivukula; Nathanael Machicoane; Louis J Kim; Michael R Levitt; Alberto Aliseda
Journal:  J Fluid Mech       Date:  2021-03-31       Impact factor: 3.627

3.  Anterior Circulation Fusiform Aneurysms Have a Lower Occlusion Rate After Pipeline Embolization Device Treatment Than Posterior Circulation Fusiform Aneurysms: A Multicenter Cohort Study.

Authors:  Chao Xu; Pei Wu; Liang Zou; Shancai Xu; Bin Luo; Xinjian Yang; Huaizhang Shi
Journal:  Front Neurol       Date:  2022-06-02       Impact factor: 4.086

4.  Determinants of intracranial aneurysm retreatment following embolization with a single flow-diverting stent.

Authors:  Justin E Vranic; Pablo Harker; Christopher J Stapleton; Robert W Regenhardt; Adam A Dmytriw; Naif M Alotaibi; Rajiv Gupta; Thabele M Leslie-Mazwi; Matthew J Koch; Scott B Raymond; Justin R Mascitelli; T Tyler Patterson; Joshua Seinfeld; Andrew White; David Case; Christopher Roark; Chirag D Gandhi; Fawaz Al-Mufti; Jared Cooper; Aman B Patel
Journal:  Neuroradiol J       Date:  2021-11-07

5.  Pipeline Embolization device for intracranial aneurysms in a large Chinese cohort: factors related to aneurysm occlusion.

Authors:  Bin Luo; Huibin Kang; Hongqi Zhang; Tianxiao Li; Jianmin Liu; Donglei Song; Yuanli Zhao; Sheng Guan; Aisha Maimaitili; Yunyan Wang; Wenfeng Feng; Yang Wang; Jieqing Wan; Guohua Mao; Huaizhang Shi; Xinjian Yang
Journal:  Ther Adv Neurol Disord       Date:  2020-11-02       Impact factor: 6.570

6.  Complex cerebral aneurysms: intra-luminal reconstruction using Pipeline flow-diverting stent and the obliteration mechanism.

Authors:  Xianli Lv; Chuhan Jiang; Zhongxue Wu; Weijian Jiang; Guihuai Wang
Journal:  Neuroradiol J       Date:  2019-12-11

7.  Extracranial-intracranial high-flow bypass as a rescue therapy for incomplete cerebral aneurysm occlusion after flow diversion: A case report.

Authors:  Tomoya Kamide; Kouichi Misaki; Takehiro Uno; Akifumi Yoshikawa; Naoyuki Uchiyama; Mitsutoshi Nakada
Journal:  Surg Neurol Int       Date:  2021-02-17

8.  Long-term Follow-up Results after Flow Diverter Therapy Using the Pipeline Embolization Device for Large or Giant Unruptured Internal Carotid Artery Aneurysms: Single-center Retrospective Analysis in the Japanese Population.

Authors:  Takashi Fujii; Kohsuke Teranishi; Kenji Yatomi; Kazumoto Suzuki; Yumiko Mitome-Mishima; Akihide Kondo; Hidenori Oishi
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-10-27       Impact factor: 1.742

9.  Quantitative magnetic resonance angiography to assess post embolization hemodynamics following pipeline embolization.

Authors:  Timothy G White; Brendan Ryu; Kevin A Shah; Justin Turpin; Karen Black; Thomas Link; Amir R Dehdashti; Jeffrey M Katz; Henry H Woo
Journal:  Interv Neuroradiol       Date:  2021-06-20       Impact factor: 1.764

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.